A few days ago, the Moers-based medical technology company Medipee was a guest at the world’s largest face-to-face congress of the German Society of Urology (DGU) in Stuttgart. On site, the representatives of the company Medipee discussed with doctors and experts about various applications of their invention.
The focus of this year’s congress was, among other things, the treatment and handling of urological tumors as well as the therapy of urinary and kidney stones. Medipee is currently working on an application for urinary and kidney stone patients. This is intended to support patients after a stone operation in metaphylaxis and to be offered as a digital health application (DiGA) within the framework of the Digital Care Act.
Medipee has already been able to identify sufficient assumptions for the positive care effects of such an app in a pilot study in cooperation with the University Hospital Oldenburg. “We now want to prove the effect of our app in an evidence study in cooperation with various clinics and over 150 participants,” explains Frank Willems, medical technology engineer and managing director of Medipee GmbH. The Moers-based medical start-up was able to find appropriate study partners at the DGU Congress in Stuttgart: “We have had very positive discussions with renowned urologists from the DACH region and are now in joint preparations for the start of a larger study,” Willems continues.
